OOS Investigation — What FDA Still Expects in 2026
Barr still rules retesting. FDA's OOS guidance got a Level 2 revision in 2022, not a rewrite. Phase I/II files, averaging, and CAPA linkage under inspection.
Read full articlePractical articles, guides, and templates for regulated quality teams — from Part 11 and Annex 11 depth to checklists you can use in deviations and validation. Prefer structured traceability over spreadsheets? Pair these resources with the Excel to controlled workflows solution path.
Barr still rules retesting. FDA's OOS guidance got a Level 2 revision in 2022, not a rewrite. Phase I/II files, averaging, and CAPA linkage under inspection.
Read full article
Quality insights, compliance commentary, and operating guidance for regulated life-sciences teams.
Browse the blog
In-depth playbooks covering validation, data integrity, Part 11, Annex 11, and eQMS selection.
Browse guides
Downloadable working files for deviation investigations, change impact assessments, training matrices, and more.
Browse templates
Quick answers to common questions about Complere, regulated rollout, compliance, and implementation.
Browse FAQs
Plain-language definitions of quality and compliance terms used by regulatory teams and inspectors.
Browse the glossary
Estimate hours recovered and cost avoided when deviations, CAPA, audits, and training move off spreadsheets and email.
Open the calculatorGet practical updates, new resources, and rollout guidance tailored for regulated quality teams.